using integrative multiomics to explain myeloma progression and evolution of refractory disease
Published 1 month ago • 33 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
0:59
defining the origins of multiple myeloma
-
2:35
resistance to immunotherapy in multiple myeloma: mechanisms & monitoring
-
2:05
multiomics profiling of mrd to understand the biology of drug resistance in multiple myeloma
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
1:39
understanding mechanisms of resistance in myeloma
-
1:53
the future of multiple myeloma treatment
-
5:16
the evolution of al amyloidosis therapy
-
1:55
mgus progression to overt myeloma: the tumor microenvironment
-
10:20
understanding multiple myeloma (multiple myeloma explained clearly)
-
4:04
the future of myeloma treatment and the possibility of cure
-
4:47
multiple myeloma - mayo clinic
-
2:25
new insight into the biology of multiple myeloma: from clonal evolution to new treatment options
-
2:37
meta-analysis of studies on biomarker-defined early multiple myeloma
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
5:41
ctcs in myeloma: egression mechanisms, transcriptomics, and prognostic value
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
4:32
primary refractory young myeloma: a difficult clinical situation
-
1:03
multiple myeloma: what needs to change to improve care?
-
1:02
optimizing multiple myeloma treatment
-
1:32
the use of multi-omics to understand the progression from mgus to wm